Free Trial

Alignment Healthcare (NASDAQ:ALHC) Stock Price Down 4.5% - What's Next?

Alignment Healthcare logo with Medical background

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) shares traded down 4.5% during mid-day trading on Wednesday . The company traded as low as $13.28 and last traded at $13.57. 761,998 shares changed hands during mid-day trading, a decline of 65% from the average session volume of 2,154,117 shares. The stock had previously closed at $14.21.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on ALHC shares. UBS Group upped their price target on Alignment Healthcare from $16.00 to $17.00 and gave the company a "neutral" rating in a research report on Friday, May 2nd. Stephens raised Alignment Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Stifel Nicolaus increased their price target on Alignment Healthcare from $18.00 to $23.00 and gave the stock a "buy" rating in a research note on Tuesday, April 8th. Finally, Robert W. Baird raised their target price on Alignment Healthcare from $17.00 to $22.00 and gave the company an "outperform" rating in a research note on Tuesday, April 15th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, six have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, Alignment Healthcare has an average rating of "Moderate Buy" and a consensus price target of $17.17.

View Our Latest Stock Report on Alignment Healthcare

Alignment Healthcare Price Performance

The stock has a market capitalization of $2.81 billion, a price-to-earnings ratio of -29.63 and a beta of 1.16. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 2.95. The stock has a 50-day simple moving average of $15.01 and a 200 day simple moving average of $15.13.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The company reported ($0.05) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.12) by $0.07. The business had revenue of $926.93 million during the quarter, compared to analyst estimates of $889.83 million. Alignment Healthcare had a negative return on equity of 80.49% and a negative net margin of 3.02%. The firm's revenue was up 47.5% on a year-over-year basis. During the same period in the previous year, the company earned ($0.25) EPS. On average, equities research analysts forecast that Alignment Healthcare, Inc. will post -0.69 EPS for the current fiscal year.

Insider Buying and Selling at Alignment Healthcare

In other Alignment Healthcare news, President Dawn Christine Maroney sold 30,000 shares of the business's stock in a transaction dated Monday, June 16th. The stock was sold at an average price of $14.48, for a total value of $434,400.00. Following the completion of the sale, the president owned 2,072,899 shares of the company's stock, valued at $30,015,577.52. The trade was a 1.43% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Atlantic (Aln Hlth) L. General sold 17,000,000 shares of the firm's stock in a transaction that occurred on Monday, May 19th. The shares were sold at an average price of $15.28, for a total value of $259,760,000.00. Following the completion of the transaction, the director directly owned 44,302,175 shares in the company, valued at $676,937,234. The trade was a 27.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 17,795,262 shares of company stock worth $272,980,496 over the last quarter. Insiders own 7.00% of the company's stock.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in ALHC. US Bancorp DE increased its position in Alignment Healthcare by 6,544.2% in the 4th quarter. US Bancorp DE now owns 98,932 shares of the company's stock worth $1,113,000 after buying an additional 97,443 shares during the period. Northern Trust Corp raised its position in shares of Alignment Healthcare by 8.6% during the fourth quarter. Northern Trust Corp now owns 908,964 shares of the company's stock worth $10,226,000 after acquiring an additional 72,063 shares during the last quarter. GAMMA Investing LLC increased its holdings in Alignment Healthcare by 3,216.9% in the first quarter. GAMMA Investing LLC now owns 23,815 shares of the company's stock valued at $443,000 after purchasing an additional 23,097 shares during the last quarter. Franklin Resources Inc. acquired a new position in Alignment Healthcare in the fourth quarter valued at about $732,000. Finally, Proficio Capital Partners LLC acquired a new position in Alignment Healthcare in the fourth quarter valued at about $184,000. 86.19% of the stock is owned by institutional investors.

Alignment Healthcare Company Profile

(Get Free Report)

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

Featured Stories

Should You Invest $1,000 in Alignment Healthcare Right Now?

Before you consider Alignment Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alignment Healthcare wasn't on the list.

While Alignment Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

ALERT: Big Tech Earnings – Watch Before Wednesday
ACT FAST! Congress is Dumping these 3 Stocks
3 “Boring” Mega Cap Stocks to Turn Into Pure Profit

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines